Luxury Guide,the U.S. FDA advises against using semaglutide during pregnancy

The safety of semaglutide during pregnancy is a crucial consideration for individuals using this medication, particularly those with type 2 diabetes or seeking weight management. While semaglutide has shown efficacy in managing blood sugar and promoting weight loss, its use during pregnancy is a complex issue with ongoing research and evolving recommendations. The U.S. FDA advises against using semaglutide during pregnancy due to potential risks to the developing fetus.

Expert opinions and emerging studies provide a nuanced perspective on semaglutide safety in pregnancy. Some research suggests that semaglutide is not recommended during pregnancy due to potential risks, including birth defects, low birth weight, and miscarriage. This cautious approach is largely due to a lack of extensive, well-controlled human studies specifically investigating the impact of semaglutide on pregnant individuals and their offspring.

However, the existing data, while limited, offers some insights. One study involving 168 pregnant women who used GLP-1 receptor agonists, including 51 who took semaglutide, reported no increased chance of birth defects was reported. Another study focused on first-trimester exposure to semaglutide also indicated no increased risk of major congenital anomalies. These findings, while encouraging for some aspects, do not negate the need for caution and professional medical guidance.

Conversely, other research highlights potential concerns. A study by Mandal (2025) suggests a higher risk of preterm birth, large for gestational age (LGA) infants, neonatal hypoglycemia, and jaundice following semaglutide exposure. This underscores the importance of carefully weighing the benefits against the potential risks to the fetus. For individuals with Type 2 diabetes, the drug should be used during pregnancy only if the benefit to the mother outweighs the risk to the fetus, as determined by a healthcare professional.

It's important to address common queries related to semaglutide and pregnancy. While some anecdotal reports and discussions, such as those around "Ozempic babies," have emerged, scientific evidence regarding semaglutide increasing fertility is not proven. For those who become pregnant while taking semaglutide or Ozempic, it is vital to consult with their healthcare provider immediately to discuss the best course of action. Questions about when to stop semaglutide before pregnancy should also be discussed with a doctor.

The current understanding is that semaglutide increases the chance of birth defects in humans has not been definitively established through comprehensive studies, but the potential for adverse pregnancy outcomes remains a significant concern. Therefore, until more robust human data becomes available, the prevailing recommendation from regulatory bodies like the U.S. FDA is to avoid semaglutide during pregnancy. This cautious stance prioritizes the well-being of the fetus and acknowledges the current limitations in scientific understanding regarding semaglutide pregnancy safety.